Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Hacettepe University, Hacettepe University Hospital
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410810637
